NLRP3 and amyotrophic lateral sclerosis: To elucidate the potential mechanism of PR-DPR on the NLRP3 inflammasome activation in microglia as a possible strategy of therapeutic intervention in C9-ALS, we first wanted to identify factors that might interact with PR50 in HMC3 cells.